Detalhe da pesquisa
1.
Nivolumab Combination Therapy in Advanced Esophageal Squamous-Cell Carcinoma.
N Engl J Med
; 386(5): 449-462, 2022 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35108470
2.
Genetic and immune landscape evolution in MMR-deficient colorectal cancer.
J Pathol
; 262(2): 226-239, 2024 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37964706
3.
Binimetinib in combination with nivolumab or nivolumab and ipilimumab in patients with previously treated microsatellite-stable metastatic colorectal cancer with RAS mutations in an open-label phase 1b/2 study.
BMC Cancer
; 24(1): 446, 2024 Apr 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-38600471
4.
Rivoceranib, a VEGFR-2 inhibitor, monotherapy in previously treated patients with advanced or metastatic gastric or gastroesophageal junction cancer (ANGEL study): an international, randomized, placebo-controlled, phase 3 trial.
Gastric Cancer
; 27(2): 375-386, 2024 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-38281295
5.
Trastuzumab deruxtecan in patients in the USA and Europe with HER2-positive advanced gastric or gastroesophageal junction cancer with disease progression on or after a trastuzumab-containing regimen (DESTINY-Gastric02): primary and updated analyses from a single-arm, phase 2 study.
Lancet Oncol
; 24(7): 744-756, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37329891
6.
Pathological regression of primary tumour and metastatic lymph nodes following chemotherapy in resectable OG cancer: pooled analysis of two trials.
Br J Cancer
; 128(11): 2036-2043, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-36966233
7.
SARS-CoV-2 Vaccine Immunogenicity in Patients with Gastrointestinal Cancer Receiving Systemic Anti-Cancer Therapy.
Oncologist
; 28(1): e1-e8, 2023 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-36342104
8.
Impact of pharmacogenomic DPYD variant guided dosing on toxicity in patients receiving fluoropyrimidines for gastrointestinal cancers in a high-volume tertiary centre.
BMC Cancer
; 23(1): 380, 2023 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37101114
9.
ctDNA guided adjuvant chemotherapy versus standard of care adjuvant chemotherapy after curative surgery in patients with high risk stage II or stage III colorectal cancer: a multi-centre, prospective, randomised control trial (TRACC Part C).
BMC Cancer
; 23(1): 257, 2023 Mar 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-36941575
10.
Ibrutinib combination therapy for advanced gastrointestinal and genitourinary tumours: results from a phase 1b/2 study.
BMC Cancer
; 23(1): 1056, 2023 Nov 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-37919668
11.
MRI-Diagnosed Tumor Deposits and EMVI Status Have Superior Prognostic Accuracy to Current Clinical TNM Staging in Rectal Cancer.
Ann Surg
; 276(2): 334-344, 2022 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32941279
12.
Pembrolizumab versus paclitaxel for previously treated PD-L1-positive advanced gastric or gastroesophageal junction cancer: 2-year update of the randomized phase 3 KEYNOTE-061 trial.
Gastric Cancer
; 25(1): 197-206, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34468869
13.
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours.
Gut
; 70(10): 1904-1913, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32883872
14.
EGFR amplification and outcome in a randomised phase III trial of chemotherapy alone or chemotherapy plus panitumumab for advanced gastro-oesophageal cancers.
Gut
; 70(9): 1632-1641, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-33199443
15.
Clinical Performance of Abbreviated Liver MRI for the Follow-Up of Patients With Colorectal Liver Metastases.
AJR Am J Roentgenol
; 216(3): 669-676, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33502225
16.
The FOCCUS study: a prospective evaluation of the frequency, severity and treatable causes of gastrointestinal symptoms during and after chemotherapy.
Support Care Cancer
; 29(3): 1443-1453, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32676853
17.
Analysis of KRAS, NRAS, BRAF, PIK3CA and TP53 mutations in a large prospective series of locally advanced rectal cancer patients.
Int J Cancer
; 146(1): 94-102, 2020 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31199501
18.
R-GEM-Lenalidomide versus R-GEM-P as second-line treatment of diffuse large B-cell lymphoma: results of the UK NRCI phase II randomised LEGEND trial.
Ann Hematol
; 99(1): 105-112, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31776726
19.
Comparison of a coaxial versus non-coaxial liver biopsy technique in an oncological setting: diagnostic yield, complications and seeding risk.
Eur Radiol
; 30(12): 6702-6708, 2020 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-32666317
20.
Real-world treatment patterns, healthcare resource use and clinical outcomes of patients receiving second line therapy for advanced or metastatic gastric cancer.
BMC Gastroenterol
; 20(1): 133, 2020 May 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32370803